Evidence map›Paper›PMID 32235738›Full record

ArticleCells2020

Lamin A and Prelamin A Counteract Migration of Osteosarcoma Cells.

Camilla Evangelisti, Francesca Paganelli, Gaia Giuntini, Elisabetta Mattioli, Alessandra Cappellini, Giulia Ramazzotti, Irene Faenza, Maria Cristina Maltarello, Alberto M Martelli, Katia Scotlandi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Lamins' role in osteosarcoma.Frontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The effect of cellular nuclear function alteration on the pathogenesis of shoulder adhesive capsulitis: an immunohistochemical study on lamin A/C expression.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2024
    Article
  9. Article
  10. AntigeneCancers · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Camilla EvangelistiCNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
Francesca PaganelliDepartment of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.
Gaia GiuntiniDepartment of Molecular and Development Medicine, Cellular and Molecular Physiology Unit, University of Siena, 53100 Siena, Italy.
Elisabetta MattioliCNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
Alessandra CappelliniDepartment of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.
Giulia RamazzottiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-9684-714X
Irene FaenzaDepartment of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-5227-3567
Maria Cristina MaltarelloLaboratory of Musculoskeletal Cell Biology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Alberto M MartelliDepartment of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-5196-7260
Katia ScotlandiExperimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Francesca ChiariniCNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
Giovanna LattanziCNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.ORCID 0000-0002-7103-8722
Istituto Ortopedico Rizzoli · ITUniversity of Bologna · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A type lamins are fundamental components of the nuclear lamina. Changes in lamin A expression correlate with malignant transformation in several cancers. However, the role of lamin A has not been explored in osteosarcoma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblasts (OBs) and OS cells. Thus, we studied the expression of lamin A/C in OS cells compared to OBs and evaluated the effects of lamin A overexpression in OS cell lines. We show that, while lamin A expression increases during osteoblast differentiation, all examined OS cell lines express lower lamin A levels relative to differentiated OBs. The condition of low

Indexed as

Cell MovementCell DifferentiationCell Line, TumorCell ProliferationHumansLamin Type ALovastatinOsteoblastsOsteosarcomaLamin Type ALovastatinprelamin Acellular migrationlamin ALMNA geneosteoblast differentiationosteosarcoma

Identifiers

PMID32235738
PMCPMC7140691
OpenAlexW3012916796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.